-
Marchés
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Vue d'ensemble
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
AMT HOLDING
Identification
Symbole
AMT
Code ISIN
NL0000886968
Trading location
Amsterdam
ICB
Pharmaceuticals&Biotechnology
Description de l'activité
Amsterdam Molecular Therapeutics (AMT) Holding B.V. is a biopharmaceutical company that develops gene-based therapies for orphan diseases.
Site internet
http://www.amtbv.com
Issuer website
http://www.amtbv.com
Operation
Date de l'IPO
mer 20/06/2007
IPO type
Initial Public Offering
Type d'IPO
Initial Public offering
Catégorie
IPO
Operation description
Offering of up to 5,000,000 new ordinary shares.
Operation calendar
Trading on Eurolist by Euronext is expected to commence on or about 20 June 2007. Settlement date is the third business day following the listing date, expected to be on or about 25 June 2007
Price range
Between €8.00 and €10.00 per offer share.